Drug/Diagnostic Co-Development Guidance Should Be Flexible – Roche Exec

FDA draft guidance on co-development of drug/ diagnostic products likely will be released before 2005, according to the Center for Drug Evaluation & Research's Lawrence Lesko, PhD